Synergy between low molecular weight heparin and platelet...

Details Synergy between low molecular weight heparin and platelet... Synergy between low molecular weight heparin and platelet...

A - Human Necessities

61

K

A61K 31/00 (2006.01) A61K 31/60 (2006.01) A61K 31/715 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2364252

This invention is directed to a combination therapy comprising the administration of a low molecular weight heparin such as tinzaparin and a platelet GPIIb/IIIa antagonist such as roxifiban for treating, preventing and reducing the risk of thromboembolic disorders.

L'invention concerne une polythérapie consistant à administrer une héparine à faible masse moléculaire telle que la tinzaparine et un antagoniste plaquettaire de GPIIb/IIIa, tel que le roxifiban, permettant de traiter, de prévenir et de réduire le risque de troubles thromboemboliques.

Affiliated with

Also associated with

Rating

Synergy between low molecular weight heparin and platelet... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergy between low molecular weight heparin and platelet..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergy between low molecular weight heparin and platelet... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1718174